Fujian Aonong Biological Technology Group Incorporation Ltd Financial Flexibility Index
Fujian Aonong Biological Technology Group Incorporation Ltd financial flexibility index. Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥79.87 Million (operating CF CN¥29.28 Million minus capex CN¥50.59 Million) represents 0% of total liabilities (CN¥5.36 Billion). Explore capital reinvestment ratio of Fujian Aonong Biological Technology Grou to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
Financial flexibility index of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025. Historical Financial Flexibility Index trend for Fujian Aonong Biological Technology Group Incorporation Ltd across 13 annual periods. Check Fujian Aonong Biological Technology Grou cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Fujian Aonong Biological Technology Group Incorporation Ltd Financial Flexibility Index by Year (2013–2025)
Fujian Aonong Biological Technology Group Incorporation Ltd financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Fujian Aonong Biological Technology Group Incorporation Ltd. For the full cash flow conversion analysis, see Fujian Aonong Biological Technology Grou operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | CN¥382.84 Million | CN¥152.94 Million | CN¥5.16 Billion | ▲ +227.6% |
| 2024 | 0.02x | CN¥145.90 Million | CN¥-116.78 Million | CN¥6.44 Billion | ▼ -78.6% |
| 2023 | 0.11x | CN¥1.50 Billion | CN¥984.01 Million | CN¥14.13 Billion | ▼ -25.4% |
| 2022 | 0.14x | CN¥2.16 Billion | CN¥663.64 Million | CN¥15.23 Billion | ▼ -34.5% |
| 2021 | 0.22x | CN¥3.23 Billion | CN¥524.29 Million | CN¥14.91 Billion | ▼ -52.4% |
| 2020 | 0.46x | CN¥3.70 Billion | CN¥406.02 Million | CN¥8.12 Billion | ▲ +57.5% |
| 2019 | 0.29x | CN¥1.05 Billion | CN¥394.16 Million | CN¥3.64 Billion | ▲ +11.4% |
| 2018 | 0.26x | CN¥596.42 Million | CN¥27.26 Million | CN¥2.30 Billion | ▼ -12.5% |
| 2017 | 0.30x | CN¥466.96 Million | CN¥26.78 Million | CN¥1.57 Billion | ▼ -18.0% |
| 2016 | 0.36x | CN¥404.74 Million | CN¥128.95 Million | CN¥1.12 Billion | ▼ -2.6% |
| 2015 | 0.37x | CN¥335.49 Million | CN¥129.24 Million | CN¥902.85 Million | ▲ +115.0% |
| 2014 | 0.17x | CN¥123.02 Million | CN¥-33.66 Million | CN¥711.92 Million | ▼ -50.3% |
| 2013 | 0.35x | CN¥210.01 Million | CN¥137.26 Million | CN¥604.09 Million | — |